Low-dose intratympanic gentamicin and the treatment of Meniere's disease: Preliminary results

Laryngoscope

Volumn 107, Issue 1, 1997, Pages 83-89

  Driscoll, Colin L W ^a   Kasperbauer, Jan L ^a   Facer, George W ^a   Harner, Stephen G ^a   Beatty, Charles W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Gentamicin; Meniere's disease; Tympanic membrane

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; AUDIOMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG EFFICACY; EARDRUM; ELECTRONYSTAGMOGRAPHY; FEMALE; HEARING LOSS; HUMAN; MALE; MENIERE DISEASE; PRIORITY JOURNAL; VERTIGO;

ABSORPTION; ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; AUDIOMETRY, PURE-TONE; ELECTRONYSTAGMOGRAPHY; FEMALE; GENTAMICINS; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TYMPANIC MEMBRANE; VERTIGO;

EID: 0031032077     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199701000-00017     Document Type: Article

References (14)

1. Schuknecht HF. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol (Stockh) 1957;132:3-42.
2. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Acta Otolaryngol (Stockh) 1991;111:671-6.
3. Beck C. Intratympanic application of gentamicin for treatment of Meniere's disease. Keio J Med 1986;35:36-41.
4. Committee on Hearing and Equilibrium. Committee on Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
5. Nedzelski JM, Chiong CM, Fradet G, et al. Intratympanic gentamicin instillation as treatment in Meniere's disease. Am J Otology 1993;14:278-82.
6. Laitakari K. Intratympanic gentamycin in severe Meniere's disease. Clin Otolaryngol 1990;15:545-8.
7. Beck C, Schmidt C. 10 years experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 1978;221:149-52.
8. Tran Ba Huy P, Meulemans A, Wassef M, et al. Gentamicin persistence in rat endolymph and perilymph after a two-day constant infusion. Antimicrob Agents Chemother 1983; 22:344-6.
9. Tran Ba Huy P, Defrennes D. Aminoglycoside ototoxicity: influence of dosage regimen on drug uptake and correlation between membrane binding and some clinical features. Acta Otolaryngol (Stockh) 1988;105:511-5.
10. Takumida M, Wersall J, Bagger Sjoback D. Initial changes in the sensory hair-cell membrane folowing aminoglycoside administration in a guinea pig model. Arch Otorhinolaryngol 1989;246:26-31.
11. Hiel H, Bennani H, Erre JP, et al. Kinetics of gentamicin in cochlear hair cells after chronic treatment. Acta Otolaryngol (Stockh) 1992;112:272-7.
12. Tange RA, Conijn EAJG, van Zeijl LGPM, Huizing EH. Pat-tern of gentamicin-induced cochlear degeneration in the guinea pig. Arch Otorhinolaryngol 1982;236:173-84.
13. Fausti SA, Henry JA, Schaffer JI, Olson DJ, et al. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis 1992;165:1026-32.
14. Dreschler W, Hulst R, Tange R, Urbanus N. The role of high-frequency audiometry in early detection of ototoxicity. Audiology 1985;24:387-95.